Skip to main content
Signal8

Vallone Carol A

SEC insider (Form 3/4/5 filer). CIK 0001422058. Director at Definium Therapeutics, Inc. (DFTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2026. Located in NEW YORK, NY.

Companies Vallone Carol A has filed insider reports for

  • Definium Therapeutics, Inc. (DFTX): Director
Vallone Carol A profile photo

Vallone Carol A

CIK: 0001422058

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Definium Therapeutics, Inc. logo
DFTX

Definium Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Definium Therapeutics, Inc. logo
    DFTX

    Definium Therapeutics, Inc.

    Sep 18, 2026
    Exercise
    Direct
    1.1K shares at avg. $35.52$39K
  • Definium Therapeutics, Inc. logo
    DFTX

    Definium Therapeutics, Inc.

    Jun 11, 2026
    Award
    Direct
    4.7K shares-
  • Mind Medicine (MindMed) Inc. logo
    MNMD

    Mind Medicine (MindMed) Inc.

    Jun 12, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    75.2K shares-

1-3 of 3